|
1
|
Heyn H, Mendez-Gonzalez J and Esteller M:
Epigenetic profiling joins personalized cancer medicine. Expert Rev
Mol Diagn. 13:473–479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith RA, Brooks D, Cokkinides V, Saslow D
and Brawley OW: Cancer screening in the United States, 2013: a
review of current American Cancer Society guidelines, current
issues in cancer screening, and new guidance on cervical cancer
screening and lung cancer screening. CA Cancer J Clin. 63:88–105.
2013. View Article : Google Scholar
|
|
3
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dawson MA and Kouzarides T: Cancer
epigenetics: from mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aran D and Hellman A: DNA methylation of
transcriptional enhancers and cancer predisposition. Cell.
154:11–13. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tolstorukov MY, Sansam CG, Lu P, et al:
Swi/Snf chromatin remodeling/tumor suppressor complex establishes
nucleosome occupancy at target promoters. Proc Natl Acad Sci USA.
110:10165–10170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pereira MA, Kramer PM, Conran PB, et al:
Effect of chloroform on dichloroacetic acid and trichloroacetic
acid-induced hypomethylation and expression of the c-myc gene and
on their promotion of liver and kidney tumors in mice.
Carcinogenesis. 22:1511–1519. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fraga MF, Ballestar E, Paz MF, et al:
Epigenetic differences arise during the lifetime of monozygotic
twins. Proc Natl Acad Sci USA. 102:10604–10609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reik W, Collick A, Norris ML, et al:
Genomic imprinting determines methylation of parental alleles in
transgenic mice. Nature. 328:248–251. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Onyango P, Jiang S, Uejima H, et al:
Monoallelic expression and methylation of imprinted genes in human
and mouse embryonic germ cell lineages. Proc Natl Acad Sci USA.
99:10599–10604. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tost J, Dunker J and Gut IG: Analysis and
quantification of multiple methylation variable positions in CpG
islands by pyrosequencing. Biotechniques. 35:152–156.
2003.PubMed/NCBI
|
|
13
|
Craig JM and Bickmore WA: The distribution
of CpG islands in mammalian chromosomes. Nat Genet. 7:376–382.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gutierrez JC, Callejas S, Borniquel S, et
al: DNA methylation in ciliates: implications in differentiation
processes. Int Microbiol. 3:139–146. 2000.PubMed/NCBI
|
|
15
|
Guintivano J, Arad M, Gould TD, et al:
Antenatal prediction of postpartum depression with blood DNA
methylation biomarkers. Mol Psychiatry. May 21–2013.(Epub ahead of
print). View Article : Google Scholar
|
|
16
|
Di Ruscio A, Ebralidze AK, Benoukraf T, et
al: DNMT1-interacting RNAs block gene-specific DNA methylation.
Nature. 503:371–376. 2013.PubMed/NCBI
|
|
17
|
Xie W, Schultz MD, Lister R, et al:
Epigenomic analysis of multilineage differentiation of human
embryonic stem cells. Cell. 153:1134–1148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang X, Monitto CL, Demokan S, et al:
Identification of hypermethylated genes associated with cisplatin
resistance in human cancers. Cancer Res. 70:2870–2879. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu X, Rauch TA, Zhong X, et al: CpG island
hypermethylation in human astrocytomas. Cancer Res. 70:2718–2727.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Daskalos A, Nikolaidis G, Xinarianos G,
Savvari P, Cassidy A, Zakopoulou R, Kotsinas A, Gorgoulis V, Field
JK and Liloglou T: Hypomethylation of retrotransposable elements
correlates with genomic instability in non-small cell lung cancer.
Int J Cancer. 124:81–87. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tan K, Kajino K, Momose S, et al:
Mesothelin (MSLN) promoter is hypomethylated in malignant
mesothelioma, but its expression is not associated with methylation
status of the promoter. Hum Pathol. 41:1330–1338. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hama R, Watanabe Y, Shinada K, et al:
Characterization of DNA hypermethylation in two cases of peritoneal
mesothelioma. Tumour Biol. 33:2031–2040. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stenvinkel P, Karimi M, Johansson S, et
al: Impact of inflammation on epigenetic DNA methylation - a novel
risk factor for cardiovascular disease? J Intern Med. 261:488–499.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Obeid R, Schadt A, Dillmann U, et al:
Methylation status and neurodegenerative markers in Parkinson
disease. Clin Chem. 55:1852–1860. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Laird PW: Principles and challenges of
genome-wide DNA methylation analysis. Nat Rev Genet. 11:191–203.
2010. View
Article : Google Scholar
|
|
26
|
Riggs AD and Jones PA: 5-methylcytosine,
gene regulation, and cancer. Adv Cancer Res. 40:1–30. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin Z, Cheng Y, Gu W, et al: A
multicenter, double-blinded validation study of methylation
biomarkers for progression prediction in Barrett’s esophagus.
Cancer Res. 69:4112–4115. 2009.PubMed/NCBI
|
|
28
|
Martinez-Galan J, Torres B, Del Moral R,
et al: Quantitative detection of methylated ESR1 and 14-3-3-sigma
gene promoters in serum as candidate biomarkers for diagnosis of
breast cancer and evaluation of treatment efficacy. Cancer Biol
Ther. 7:958–965. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Glockner SC, Dhir M, Yi JM, et al:
Methylation of TFPI2 in stool DNA: a potential novel biomarker for
the detection of colorectal cancer. Cancer Res. 69:4691–4699. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Choi JY, James SR, Link PA, et al:
Association between global DNA hypomethylation in leukocytes and
risk of breast cancer. Carcinogenesis. 30:1889–1897. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen WD, Han ZJ, Skoletsky J, et al:
Detection in fecal DNA of colon cancer-specific methylation of the
nonexpressed vimentin gene. J Natl Cancer Inst. 97:1124–1132. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gonzalez ME, Peterson EA, Privette LM, et
al: High SEPT9_v1 expression in human breast cancer cells is
associated with oncogenic phenotypes. Cancer Res. 67:8554–8564.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harbeck N, Nimmrich I, Hartmann A, et al:
Multicenter study using paraffin-embedded tumor tissue testing
PITX2 DNA methylation as a marker for outcome prediction in
tamoxifen-treated, node-negative breast cancer patients. J Clin
Oncol. 26:5036–5042. 2008. View Article : Google Scholar
|
|
34
|
Hartmann O, Spyratos F, Harbeck N, et al:
DNA methylation markers predict outcome in node-positive, estrogen
receptor-positive breast cancer with adjuvant anthracycline-based
chemotherapy. Clin Cancer Res. 15:315–323. 2009. View Article : Google Scholar
|
|
35
|
Hrasovec S, Hauptman N, Glavac D, et al:
TMEM25 is a candidate biomarker methylated and down-regulated in
colorectal cancer. Dis Markers. 34:93–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Carone BR, Fauquier L, Habib N, et al:
Paternally induced transgenerational environmental reprogramming of
metabolic gene expression in mammals. Cell. 143:1084–1096. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Papageorgiou EA, Fiegler H, Rakyan V, et
al: Sites of differential DNA methylation between placenta and
peripheral blood: molecular markers for noninvasive prenatal
diagnosis of aneuploidies. Am J Pathol. 174:1609–1618. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao F, Wang J, Liu R, et al:
Quantification and application of the placental epigenetic
signature of the RASSF1A gene in maternal plasma. Prenat Diagn.
30:778–782. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Muers M: Methylation from mother. Nat Rev
Genet. 12:62011. View
Article : Google Scholar
|
|
40
|
Wang LJ, Bai Y, Bao ZS, et al:
Hypermethylation of testis derived transcript gene promoter
significantly correlates with worse outcomes in glioblastoma
patients. Chin Med J (Engl). 126:2062–2066. 2013.PubMed/NCBI
|
|
41
|
Zheng G, Dahl JA, Niu Y, et al: ALKBH5 is
a mammalian RNA demethylase that impacts RNA metabolism and mouse
fertility. Mol Cell. 49:18–29. 2013.PubMed/NCBI
|
|
42
|
Motorin Y, Lyko F and Helm M:
5-methylcytosine in RNA: detection, enzymatic formation and
biological functions. Nucleic Acids Res. 38:1415–1430. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jurkowski TP and Jeltsch A: On the
evolutionary origin of eukaryotic DNA methyltransferases and Dnmt2.
PLoS One. 6:e281042011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Brzezicha B, Schmidt M, Makalowska I, et
al: Identification of human tRNA:m5C methyltransferase catalysing
intron-dependent m5C formation in the first position of the
anticodon of the pre-tRNA Leu (CAA). Nucleic Acids Res.
34:6034–6043. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stevens M, Cheng JB, Li D, et al:
Estimating absolute methylation levels at single-CpG resolution
from methylation enrichment and restriction enzyme sequencing
methods. Genome Res. 23:1541–1553. 2013. View Article : Google Scholar
|
